The Sorin Group
The innovations developed by the Sorin Group’s cardiopulmonary business unit have had a significant impact on the way cardiopulmonary bypass procedures are performed throughout the world, the company says. Over the past six decades, the company has influenced development of heart-lung equipment, blood management systems and accessories that enhance the efforts of surgical teams.
More than 1 million patients in 100 countries are helped by Sorin products annually, the company reports. The Sorin Group’s employees are dedicated to researching, developing and manufacturing cutting-edge technology to treat cardiovascular diseases. “Their commitment has made our company the world leader in cardiac surgery and a major global player in managing cardiac rhythm disorders and heart failure,” the company explains.